Dishy et al. [66] have attributed these inconsistencies to the multifactorial causes/mechanisms of decreased NO and subsequent endothelial dysfunction, with the possibility of being improved by PDE-5 inhibitors in some conditions but not in the others as we demonstrated here. The gene discussed is PDE5A; the disease is endothelial dysfunction.